研究单位：[1]EMD Serono ( EMD Serono Research & Development Institute,Inc. )[2]West China Hospital,Sichuan University Chengdu,China[3]Sichuan Cancer Hospital Chengdu,China[4]Torrance Health Association Redondo Beach,California,United States,90277[5]St Joseph Heritage Healthcare Santa Rosa,California,United States,95403[6]Rocky Mountain Cancer Centers,LLP Denver,Colorado,United States,80218[7]Holy Cross Hospital Inc. Fort Lauderdale,Florida,United States,33308[8]Winship Cancer Institute Atlanta,Georgia,United States,30322[9]University of Chicago Medical Center Chicago,Illinois,United States,60637[10]Ingalls Hospital Harvey,Illinois,United States,60426-3558
研究目的：
This study will look at how effective the study drug (tepotinib) is at stopping the growth and spread of lung cancer. This study will also measure a number of other things including safety of the study drug and the side effects,how body processes the study drug,or how the study drug affects your quality of life. The study also has an optional pharmacogenetic research part. Pharmacogenetic research is an important way to try to understand the role of genetics in human disease and how genes impact the effectiveness of drugs,because differences in genes can change the way a person responds to a particular drug.
